HIGHLIGHTS
- who: Loretta De Chiara et al. from the Department of Biochemistry, Genetics and Immunology, Universidade Vigo, Vigo, Spain have published the paper: Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs, in the Journal: Cancers 2022, x of /2022/
- what: The aim of this study was to determine if sCD26 and its enzymatic activity can complement the performance of FIT for the early detection of CRC and AA, analyzing these biomarkers in cohorts of cancer and average-risk populations derived from the national screening program. Considering that the objective of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.